RESEARCHER PROFILE
Anna Gilmore
A
University of Bath
Anna Gilmore works in Global Public Health Policies and Epidemiology, Smoking Behavior and Cessation, Pharmaceutical industry and healthcare, Public Health Policies and Education, Political Influence and Corporate Strategies. Recorded institutional associations include University of Bath.
417Publications
11,717Citations
60H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Defining and conceptualising the commercial determinants of health
2023 · 737 citationsExposing and addressing tobacco industry conduct in low-income and middle-income countries
2015 · 370 citationsThe Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR
2012 · 295 citationsStatus of implementation of Framework Convention on Tobacco Control (FCTC) in Ghana: a qualitative study
2010 · 289 citationsHow does the alcohol industry attempt to influence marketing regulations? A systematic review
2015 · 257 citationsHow Does the Tobacco Industry Attempt to Influence Marketing Regulations? A Systematic Review
2014 · 254 citationsThe Policy Dystopia Model: An Interpretive Analysis of Tobacco Industry Political Activity
2016 · 251 citationsCommercial determinants of health: future directions
2023 · 204 citationsWhat is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies
2012 · 185 citationsShort term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction
2010 · 161 citationsCorporate Social Responsibility and Access to Policy Élites: An Analysis of Tobacco Industry Documents
2011 · 151 citationsPrevalence of Smoking in 8 Countries of the Former Soviet Union: Results From the Living Conditions, Lifestyles and Health Study
2004 · 149 citationsUnderstanding tobacco industry pricing strategy and whether it undermines tobacco tax policy: the example of the UK cigarette market
2013 · 147 citationsPublic health, corporations and the New Responsibility Deal: promoting partnerships with vectors of disease?
2011 · 146 citationsBringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks
2019 · 145 citationsE-cigarettes and equity: a systematic review of differences in awareness and use between sociodemographic groups
2016 · 141 citationsIs the increasing policy use of Impact Assessment in Europe likely to undermine efforts to achieve healthy public policy?
2010 · 138 citationsEnvironmental Profile of a Community's Health (EPOCH): An Instrument to Measure Environmental Determinants of Cardiovascular Health in Five Countries
2010 · 138 citationsThe Science for Profit Model—How and why corporations influence science and the use of science in policy and practice
2021 · 138 citationsConceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations
2023 · 124 citationsTobacco Industry Influence on Science and Scientists in Germany
2005 · 122 citationsCorporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy
2023 · 119 citationsMoving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union—part I: establishing cigarette imports
2004 · 117 citationsTrends in the prevalence of smoking in Russia during the transition to a market economy
2007 · 112 citations“Working the System”—British American Tobacco's Influence on the European Union Treaty and Its Implications for Policy: An Analysis of Internal Tobacco Industry Documents
2010 · 109 citations
